Long-Term Outcomes Of Intensive Inpatient Care For Severe, Resistant Obsessive-Compulsive Disorder

Objective:A substantial proportion of severely ill patients with obsessive-compulsive disorder (OCD) do not respond to serotonin reuptake inhibitors (SRIs) and are unable to practice cognitive behavioral therapy (CBT) on an out-patient basis. We report the short-term (at discharge) and long-term (up to 2 years) outcome of a multimodal inpatient treatment program that included therapist-assisted intensive CBT with adjunctive pharmacotherapy for severely ill OCD patients who are often resistant to SRIs and are either unresponsive or unable to practice outpatient CBT.Methods:A total of 420 patients, admitted between January 2012 and December 2017 were eligible for the analysis. They were evaluated using the Mini International Neuropsychiatric Interview, the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the Clinical Global Impression (CGI) scale. All patients received 4 to 5 therapist-assisted CBT sessions per week along with standard pharmacotherapy. Naturalistic follow-up information at 3, 6, 12, and 24 months were recorded.Results:At baseline, patients were mostly severely ill (YBOCS = 29.9 +/- 4.5) and nonresponsive to >= 2 SRIs (83%). Mean duration of inpatient stay was 42.7 +/- 25.3 days. At discharge, there was a significant decline in the mean YBOCS score (29.9 +/- 4.5 vs. 18.1 +/- 7.7, P < .001, Cohen's d = 1.64); 211/420 (50%) were responders (>= 35% YBOCS reduction and CGI-I <= 2) and an additional 86/420 (21%) were partial responders (25% to 35% YBOCS reduction and CGI-I <= 3). Using latent class growth modeling of the follow-up data, 4 distinct classes were identified, which include "remitters" (14.5%), "responders" (36.5%), "minimal responders" (34.7%), and "nonresponders" (14.6%). Shorter duration of illness, better insight, and lesser contamination/washing symptoms predicted better response in both short- and long-term follow-up.Conclusion:Intensive, inpatient-based care for OCD may be an effective option for patients with severe OCD and should be considered routinely in those who do not respond with outpatient treatment.